Stay updated on Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    A new Revision: v3.5.4 tag was added and the previous Revision: v3.5.3 tag was removed, indicating an updated revision of the page content. This is an administrative update with no direct user-facing changes.
    Difference
    0.0%
    Check dated 2026-05-14T23:12:35.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.3, replacing the previous Revision: v3.5.2, indicating a newer revision of the page content.
    Difference
    0.0%
    Check dated 2026-04-30T16:57:22.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Site revision label updated from v3.5.0 to v3.5.2. This appears to be a build/metadata change and does not affect study content or user interactions on the page.
    Difference
    0.0%
    Check dated 2026-04-16T11:00:36.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The site revision was updated to v3.5.0 and the previous v3.4.3 revision was removed.
    Difference
    0.0%
    Check dated 2026-03-18T18:06:22.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Revision: v3.4.3 updates the site's version label. No visible changes to study details or patient-facing information.
    Difference
    0.0%
    Check dated 2026-03-11T15:14:53.000Z thumbnail image
  9. Check
    109 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the prior operating-status notice (Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:55:35.000Z thumbnail image

Stay in the know with updates to Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.